2015/3 GaBI Journal Table of Contents

Published in: Volume 4 / Year 2015 / Issue 3
Category: 2015/3 GaBI Journal Table of Contents
Visits: 2086 total, 2 today

Contents

Editor’s Letter

Latest features in GaBI Journal, 2015, Issue 3

Editorial

Advances in analytical characterization of biosimilars

Letters to the Editor

Access to safe and effective biopharmaceuticals

Commentary

The challenges of nomenclature – INN, biosimilars and biological qualifiers

Review Article

Biosimilars patent litigation in the EU and the US: a comparative strategic overview

Biosimilars: extrapolation of clinical use to other indications

Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future

Perspective

The implementation of generics in France

Substantial savings with generics in Austria – and still room for more

Meeting Report

First Latin American educational workshop on similar biotherapeutic products, Mexico City, Mexico, 20 January 2015

European biosimilars conference highlights extrapolation as key issue

Regulatory

Regulatory requirements for the development and registration of biosimilars in South Africa

Go Back Print

Leave a Reply